Other research analysts also recently issued research reports about the company. Peel Hunt restated a buy rating and issued a GBX 380 ($5.00) target price on shares of ConvaTec Group PLC in a research note on Thursday, August 3rd. Numis Securities Ltd downgraded ConvaTec Group PLC to a reduce rating and cut their target price for the stock from GBX 276 ($3.63) to GBX 260 ($3.42) in a research note on Tuesday, July 11th. Goldman Sachs Group, Inc. (The) restated a buy rating and issued a GBX 340 ($4.47) target price on shares of ConvaTec Group PLC in a research note on Thursday, August 3rd. Deutsche Bank AG raised their target price on ConvaTec Group PLC from GBX 330 ($4.34) to GBX 335 ($4.40) and gave the stock a buy rating in a research note on Monday, August 21st. Finally, J P Morgan Chase & Co cut their target price on ConvaTec Group PLC from GBX 318 ($4.18) to GBX 303 ($3.98) and set an overweight rating for the company in a research note on Friday, August 4th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have issued a buy rating to the company’s stock. The stock presently has an average rating of Hold and an average target price of GBX 309.60 ($4.07).
ConvaTec Group PLC (LON:CTEC) traded up 0.54% on Wednesday, reaching GBX 280.90. The company had a trading volume of 2,594,660 shares. ConvaTec Group PLC has a 12-month low of GBX 213.00 and a 12-month high of GBX 349.10. The stock’s market capitalization is GBX 5.48 billion. The stock’s 50-day moving average price is GBX 276.15 and its 200-day moving average price is GBX 296.75.
The firm also recently declared a dividend, which will be paid on Friday, October 20th. Shareholders of record on Thursday, September 7th will be issued a GBX 1.06 ($0.01) dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a dividend yield of 0.36%.
ConvaTec Group PLC Company Profile
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.
What are top analysts saying about ConvaTec Group PLC? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for ConvaTec Group PLC and related companies.